Plantago Pyrite

Manufacturer: Uriel Pharmacy Inc.
Effective date: 2018-06-06
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: full-release
Hydrated at: 2026-06-01 02:10:16

Label at a glance#

ProductPlantago Pyrite

Active ingredientECHINACEA, UNSPECIFIED, PICEA ABIES LEAF, PLANTAGO MAJOR LEAF, SAGE, FERROSOFERRIC PHOSPHATE, BRYONIA ALBA ROOT, EUPATORIUM CANNABINUM FLOWERING TOP, BEEF LUNG, THYROID, BOVINE, FERROUS DISULFIDE, BOS TAURUS NASAL MUCOSA

Label structure9 sections

Contacts and useful links#

PhoneLabel contact866.642.2858

Websitewww.urielpharmacy.com

www.urielpharmacy.com

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Directions: FOR ORAL USE ONLY.

DOSAGE & ADMINISTRATION SECTION

Dissolve pellets under the tongue 3-4 times daily. Ages 12 and older: 10 pellets. Ages 2-11: 5 pellets. Under age 2: Consult a doctor.

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Echinacea (Purple coneflower) 3X, Abies (White fir) 6X, Plantago (Ribwort plantain) 6X, Salvia (Sage) 6X, Vivianite (Nat. ferrous phosphate) 7X, Bryonia (White bryony) 8X, Eupatorium can. (Hemp agrimony) 8X, Bronchi (Bovine bronchi) 17X, Larynx (Bovine larynx) 17X, Pyrite (Nat. Iron disulfide) 17X, Tunica mucosa nasi (Bovine nasal mucosa) 17X

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Sucrose, Lactose

OTC - PURPOSE SECTION

Use: Temporary relief of cough.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

WARNINGS SECTION

Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Contains sugar. Diabetics and persons intolerant of sucrose (sugar): Consult a doctor before use. Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing.

OTC - QUESTIONS SECTION

Questions? Call 866.642.2858 Uriel, East Troy WI 53120 www.urielpharmacy.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PlantagoPyritePellets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
48951-8037-2	Plantago Pyrite	1350 in 1 BOTTLE, GLASS	PELLET	1350		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
48951-8037	PLANTAGO PYRITE PELLET [URIEL PHARMACY INC.]	3	Legacy NDC, 1 package rows	20180606_af48af90-92ff-4d1a-805c-de97660fd10d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BEEF LUNG	ACTIVE INGREDIENT	2I1RTO1MBR	1
BOS TAURUS NASAL MUCOSA	ACTIVE INGREDIENT	343455G79K	1
BRYONIA ALBA ROOT	ACTIVE INGREDIENT	T7J046YI2B	1
ECHINACEA, UNSPECIFIED	ACTIVE INGREDIENT	4N9P6CC1DX	1
EUPATORIUM CANNABINUM	ACTIVE INGREDIENT	A5296YC7FS	1
FERROSOFERRIC PHOSPHATE	ACTIVE INGREDIENT	91GQH8I5F7	1
FERROUS DISULFIDE	ACTIVE INGREDIENT	132N09W4PR	1
PICEA ABIES LEAF	ACTIVE INGREDIENT	9455B15KVJ	1
PLANTAGO MAJOR LEAF	ACTIVE INGREDIENT	7DC28K241X	1
SAGE	ACTIVE INGREDIENT	065C5D077J	1
THYROID, BOVINE	ACTIVE INGREDIENT	MN18OTN73W	1
BEEF LUNG	ACTIVE MOIETY	2I1RTO1MBR	1
BOS TAURUS NASAL MUCOSA	ACTIVE MOIETY	343455G79K	1
BRYONIA ALBA ROOT	ACTIVE MOIETY	T7J046YI2B	1
ECHINACEA, UNSPECIFIED	ACTIVE MOIETY	4N9P6CC1DX	1
EUPATORIUM CANNABINUM	ACTIVE MOIETY	A5296YC7FS	1
FERROSOFERRIC PHOSPHATE	ACTIVE MOIETY	91GQH8I5F7	1
FERROUS CATION	ACTIVE MOIETY	GW89581OWR	1
PICEA ABIES LEAF	ACTIVE MOIETY	9455B15KVJ	1
PLANTAGO MAJOR LEAF	ACTIVE MOIETY	7DC28K241X	1
SAGE	ACTIVE MOIETY	065C5D077J	1
THYROID, BOVINE	ACTIVE MOIETY	MN18OTN73W	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

Plantago Pyrite
SUCROSE
ECHINACEA, UNSPECIFIED
PICEA ABIES LEAF
PLANTAGO MAJOR LEAF
SAGE
FERROSOFERRIC PHOSPHATE
BRYONIA ALBA ROOT
EUPATORIUM CANNABINUM FLOWERING TOP
BEEF LUNG
THYROID, BOVINE
FERROUS DISULFIDE
FERROUS CATION
BOS TAURUS NASAL MUCOSA

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
48951-8037	48951-8037-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
ECHINACEA, UNSPECIFIED	4N9P6CC1DX	ACTIB
PICEA ABIES LEAF	9455B15KVJ	ACTIB
PLANTAGO MAJOR LEAF	7DC28K241X	ACTIB
SAGE	065C5D077J	ACTIB
FERROSOFERRIC PHOSPHATE	91GQH8I5F7	ACTIB
BRYONIA ALBA ROOT	T7J046YI2B	ACTIB
EUPATORIUM CANNABINUM FLOWERING TOP	A5296YC7FS	ACTIB
BEEF LUNG	2I1RTO1MBR	ACTIB
THYROID, BOVINE	MN18OTN73W	ACTIB
FERROUS DISULFIDE	132N09W4PR	ACTIB
BOS TAURUS NASAL MUCOSA	343455G79K	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
6dfb41b0-b647-60db-e053-2991aa0a95a3			af48af90-92ff-4d1a-805c-de97660fd10d	2018-06-06	Warnings	Exact identifier spl id: 6dfb41b0-b647-60db-e053-2991aa0a95a3 spl set id: af48af90-92ff-4d1a-805c-de97660fd10d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.